| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/09/2005 | CN1590375A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1590374A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same |
| 03/09/2005 | CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 03/09/2005 | CN1192019C Cyclic amine derivatives |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/09/2005 | CN1192015C Cell adhesion inhibitors |
| 03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
| 03/08/2005 | US6864392 α-Sulfin and α-Sulfonamino amide derivatives |
| 03/08/2005 | US6864385 Process for the preparation of 4-haloalkylnicotinonitriles |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864290 Statine derivatives for the treatment of Alzheimer's disease |
| 03/08/2005 | US6864289 Insecticides |
| 03/08/2005 | US6864267 Calcilytic compounds |
| 03/08/2005 | US6864265 Chemokine receptor binding heterocyclic compounds |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864261 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5 |
| 03/08/2005 | US6864219 Substituted aryl ketones |
| 03/08/2005 | US6863838 Low melting point |
| 03/08/2005 | CA2164685C Method for producing an alcohol |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 03/03/2005 | WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 03/03/2005 | WO2005019151A1 Ppar modulators |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2005018557A2 Substituted pyridinones |
| 03/03/2005 | WO2004029212A3 In vivo gene silencing by chemically modified and stable sirna |
| 03/03/2005 | US20050049285 Controlling unwanted microorganisms in plants; reduced toxicity, well tolerated; synthesis |
| 03/03/2005 | US20050049281 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones |
| 03/03/2005 | US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction |
| 03/03/2005 | DE10336497A1 New 2,3,4,6-tetra-substituted pyridines, useful as pharmaceuticals and plant-protection agents, prepared using an alkoxyallene as three-carbon synthon |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535714A1 Phenoxyacetic acid derivatives |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1509574A1 Yellow anionic disazo dyes |
| 03/02/2005 | EP1509573A1 Anthraquinone-azo dyes |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509502A1 Method of forming a carbon-carbon or carbon-heteroatom linkage |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1086082B9 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP1012141B1 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589262A Cyanoguanidine prodrugs |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1191251C Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 03/02/2005 | CN1191235C Process for preparign substd. pyridines compounds |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861531 2,6-pyridine dicarboxylic acid is converted to corresponding 2,6-dicarbonyl dichloride, the dichloride is converted to a 2,6-pyridine-bis(2-alkoxyalkyl)carboxamide, the carboxamide treated with alkali metal salt, then trialkyl silicon halide |
| 03/01/2005 | US6861456 Photosensitive compound, photosensitive resin, and photosensitive composition |
| 03/01/2005 | US6861448 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
| 03/01/2005 | US6861439 Treatment of cerebrovascular disease |
| 03/01/2005 | US6861438 7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; herpes viricides |
| 03/01/2005 | CA2270243C Polymerization of ethylene with specific iron or cobalt complexes, novel pyridinebis(imines) and novel complexes of pyridinebis(imines) with iron and cobalt |
| 02/24/2005 | WO2005016984A1 Novel catalysts for selective isocyanate dimerisation |
| 02/24/2005 | WO2005016887A1 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides |
| 02/24/2005 | WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016505A2 Method for the manufacture of cyanopyridines and catalysts suitable therefor |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016342A1 Sir2 regulation |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016228A2 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 02/24/2005 | WO2004046103A3 Arylpyridine compounds |
| 02/24/2005 | WO2004031175A3 N-substituted-2-oxodihydropyridine derivatives as npy antagonists |
| 02/24/2005 | US20050043556 2,2'-Bis(triphenylphosphino)biphenyls complexed with a transition metal-diamine complex; highly active and selective hydrogenation catalysts for the hydrogenation of ketones and imines to alcohols and amines, respectively, used as drug intermediates often required in single isomer form; very low loading |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043370 Therapy for acquired immune deficiency or aids related complex; compound containing ketone and carboxy groups |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043295 Pharmaceutically effective compounds |
| 02/24/2005 | US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia |
| 02/24/2005 | US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits |
| 02/24/2005 | US20050039268 Use of dicatonic compounds for dyeing human keratinous fibres and compositions containing the same |
| 02/24/2005 | DE10336184A1 Neue Katalysatoren für die selektive Isocyanatdimerisierung New catalysts for the selective isocyanate dimerization |
| 02/24/2005 | DE10335454A1 Novel VPO catalysts for use in production of cyanopyridines by ammoxidation reaction of methylpyridines also contain transition metals |
| 02/24/2005 | DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535483A1 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | CA2534852A1 Novel catalysts for selective isocyanate dimerisation |
| 02/24/2005 | CA2532100A1 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides |
| 02/24/2005 | CA2531253A1 Sir2 regulation |
| 02/23/2005 | EP1508569A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |